Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT) (COACT)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2010 by The Catholic University of Korea.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Seoul St. Mary's Hospital
Bucheon St. Mary's Hospital
St.Paul's Hospital, Korea
Incheon St.Mary's Hospital
Saint Vincent's Hospital, Korea
Daejeon St. Mary's hospital
Information provided by:
The Catholic University of Korea
ClinicalTrials.gov Identifier:
NCT01239914
First received: November 12, 2010
Last updated: August 24, 2012
Last verified: July 2010
  Purpose
COACT registry is a multicenter registry of consecutive patients undergoing coronary stent implantation at 8 centers in the Catholic University of Korea to evaluate the real world management of patients with coronary artery disease and to assess their in-hospital, medium and long-term outcomes.

Condition
Drug Eluting Stent
Coronary Artery Disease
Polymorphism
Cholesterol
Biomarker

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

Further study details as provided by The Catholic University of Korea:

Primary Outcome Measures:
  • All causes mortality [ Time Frame: 6month, each year ] [ Designated as safety issue: Yes ]
  • Cardiac death [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Myocardial infarction [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • target lesion revascularization [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • target vessel revascularization [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • non target vessel revascularization [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Stent thrombosis [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Serum databank for evaluation of biomarkers outcomes [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]

Biospecimen Retention:   Samples With DNA
Whole blood, serum and DNA

Estimated Enrollment: 11000
Study Start Date: January 2005
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all comers who admitted cardiovascular center for coronary stent implantation
Criteria

Inclusion Criteria:

  • all consecutive patients who underwent percutaneous coronary intervention
  • written informed consent for the DNA and serum databank

Exclusion Criteria:

  • patients who did not agreed to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01239914

Locations
Korea, Republic of
Bucheon St.Mary Hospital
Bucheon, Gyeonggido, Korea, Republic of
St.Vincent's Hospital
Suwon, Gyeonggido, Korea, Republic of
Uijeongbu St.Mary's Hospital
Uijeongbu, Gyeonggido, Korea, Republic of
Daejeon St.Mary's Hospital
Daejeon, Korea, Republic of
Incheon St.Mary's Hospital
Incheon, Korea, Republic of
Seoul St.Mary's Hospital
Seoul, Korea, Republic of, 137-701
St.Paul's Hospital
Seoul, Korea, Republic of
Yeouido St.Mary Hospital
Seoul, Korea, Republic of
Sponsors and Collaborators
The Catholic University of Korea
Seoul St. Mary's Hospital
Bucheon St. Mary's Hospital
St.Paul's Hospital, Korea
Incheon St.Mary's Hospital
Saint Vincent's Hospital, Korea
Daejeon St. Mary's hospital
Investigators
Study Chair: Ki-Bae Seung, M.D.,PhD Seoul St. Mary's Hospital
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Ki-Bae Seung, Seoul St.Mary's Hospital
ClinicalTrials.gov Identifier: NCT01239914     History of Changes
Other Study ID Numbers: COACT 
Study First Received: November 12, 2010
Last Updated: August 24, 2012
Health Authority: Korea: Food and Drug Administration

Keywords provided by The Catholic University of Korea:
drug eluting stent
coronary artery disease
Korean registry

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on January 17, 2017